Total Payments
$640.46
2024 Payments
$76.59
Companies
6
Transactions
18
Medicare Patients
396
Medicare Billing
$23,674
Payment Breakdown by Category
Food & Beverage$540.46 (84.4%)
Research$100.00 (15.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $540.46 | 16 | 84.4% |
| Unspecified | $100.00 | 2 | 15.6% |
Payments by Type
General
$540.46
16 transactions
Research
$100.00
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Hologic, LLC | $238.54 | 3 | $0 (2021) |
| ABBVIE INC. | $228.52 | 9 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $100.00 | 2 | $0 (2017) |
| Astellas Pharma US Inc | $38.94 | 2 | $0 (2024) |
| Biogen, Inc. | $22.86 | 1 | $0 (2024) |
| CooperSurgical, Inc. | $11.60 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $76.59 | 3 | ABBVIE INC. ($33.43) |
| 2023 | $178.19 | 7 | ABBVIE INC. ($178.19) |
| 2022 | $16.90 | 1 | ABBVIE INC. ($16.90) |
| 2021 | $53.64 | 2 | Hologic, LLC ($35.00) |
| 2019 | $11.60 | 1 | CooperSurgical, Inc. ($11.60) |
| 2018 | $24.85 | 1 | Hologic, LLC ($24.85) |
| 2017 | $278.69 | 3 | HOLOGIC INC ($178.69) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Biological | ||||||
| 06/12/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Neurology | ||||||
| 02/02/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $33.43 | General |
| Category: WOMENS HEALTH | ||||||
| 12/26/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $33.43 | General |
| Category: WOMENS HEALTH | ||||||
| 11/16/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $34.67 | General |
| Category: WOMENS HEALTH | ||||||
| 09/22/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $34.67 | General |
| Category: WOMENS HEALTH | ||||||
| 07/31/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $30.19 | General |
| Category: WOMENS HEALTH | ||||||
| 07/31/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $1.71 | General |
| Category: WOMENS HEALTH | ||||||
| 06/28/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: WOMENS HEALTH | ||||||
| 05/22/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $34.29 | General |
| Category: WOMENS HEALTH | ||||||
| 04/26/2022 | ABBVIE INC. | ORILISSA (Drug), LO LOESTRIN FE, ORIAHNN | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: WOMENS HEALTH | ||||||
| 09/22/2021 | Hologic, LLC | ACESSA PROVU SYSTEM (Device) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Surgical | ||||||
| 06/07/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: UROLOGY | ||||||
| 07/16/2019 | CooperSurgical, Inc. | Paragard (Device) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Endocrinology | ||||||
| 04/03/2018 | Hologic, LLC | Aquilex (Device), MYOSURE, NOVASURE | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Surgical | ||||||
| 12/08/2017 | Merck Sharp & Dohme Corporation | IMPLANON (Drug) | — | Cash or cash equivalent | $50.00 | Research |
| Study: Nexplanon Observational Risk Assessment Study NORA • Category: WOMENS HEALTH | ||||||
| 04/11/2017 | Merck Sharp & Dohme Corporation | IMPLANON (Drug) | — | Cash or cash equivalent | $50.00 | Research |
| Study: Nexplanon Observational Risk Assessment Study NORA • Category: WOMENS HEALTH | ||||||
| 03/22/2017 | HOLOGIC INC | NovaSure and MyoSure (Device) | Food and Beverage | In-kind items and services | $178.69 | General |
| Category: Surgical | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Nexplanon Observational Risk Assessment Study NORA | Merck Sharp & Dohme Corporation | $100.00 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 125 | 138 | $31,784 | $7,855 |
| 2022 | 4 | 86 | 102 | $18,638 | $4,765 |
| 2021 | 3 | 87 | 96 | $16,736 | $5,422 |
| 2020 | 3 | 98 | 108 | $16,868 | $5,631 |
Total Patients
396
Total Services
444
Medicare Billing
$23,674
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 39 | $9,867 | $2,532 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 32 | $11,392 | $2,295 | 20.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 37 | 37 | $3,552 | $1,407 | 39.6% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 11 | 11 | $3,971 | $1,044 | 26.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 19 | $3,002 | $576.23 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 32 | $6,784 | $1,645 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 21 | $6,531 | $1,307 | 20.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 30 | 30 | $2,825 | $1,117 | 39.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 19 | $2,498 | $696.54 | 27.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 31 | $7,781 | $2,507 | 32.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 38 | $6,498 | $1,899 | 29.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 27 | 27 | $2,457 | $1,016 | 41.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 43 | 52 | $8,892 | $2,708 | 30.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 38 | 38 | $3,458 | $1,472 | 42.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 18 | $4,518 | $1,451 | 32.1% |
About Dr. Tamara Medley, MD
Dr. Tamara Medley, MD is a Obstetrics & Gynecology healthcare provider based in Grants Pass, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1053314377.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tamara Medley, MD has received a total of $640.46 in payments from pharmaceutical and medical device companies, with $76.59 received in 2024. These payments were reported across 18 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($540.46).
As a Medicare-enrolled provider, Medley has provided services to 396 Medicare beneficiaries, totaling 444 services with total Medicare billing of $23,674. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Grants Pass, OR
- Active Since 05/31/2005
- Last Updated 02/16/2015
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1053314377
Products in Payments
- LILETTA (Drug) $211.62
- NovaSure and MyoSure (Device) $178.69
- IMPLANON (Drug) $100.00
- ACESSA PROVU SYSTEM (Device) $35.00
- Aquilex (Device) $24.85
- ZURZUVAE (Drug) $22.86
- Veozah (Drug) $20.30
- MYRBETRIQ (Drug) $18.64
- ORILISSA (Drug) $16.90
- Paragard (Device) $11.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Grants Pass
Thomas Eagan, D.o,, D.O,
Obstetrics & Gynecology — Payments: $6,052
Obstetrics & Gynecology $6,052
Kendra Bloomfield, Md, MD
Obstetrics & Gynecology — Payments: $1,019
Obstetrics & Gynecology $1,019
Dr. Felicia Cohen, M.d, M.D
Obstetrics & Gynecology — Payments: $803.14
Obstetrics & Gynecology $803.14
Caroline Kelly, Md, MD
Obstetrics & Gynecology — Payments: $589.43
Obstetrics & Gynecology $589.43